Home » Topics » Regulatory

Regulatory
RSS

The antiplatelet agent triflusal now shown to inhibit NF-kappaB activation

Jan. 10, 2000

Olanzapine and fluoxetine in combination useful for refractory depression

Jan. 10, 2000

Miltefosine tested as oral treatment for leishmaniasis

Jan. 4, 2000

CFC-free flunisolide to be developed by 3M/Forest partnership

Jan. 3, 2000

NDA filed for intranasal scopolamine during fourth quarter

Jan. 3, 2000

FDA approves Ligand's Targretin Capsules for treatment of CTCL

Dec. 30, 1999

AstraZeneca seeks approval of Atacand HCT in the U.S.

Dec. 30, 1999

Reboxetine + pindolol rapidly relieves symptoms of depression and other CNS disorders

Dec. 30, 1999

Injectable levocarnitine approved for use in dialysis in U.S.

Dec. 28, 1999

FDA clears Taxotere for marketing in NSCLC

Dec. 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...